vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $270.7M, roughly 1.0× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 0.7%, a 14.2% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs -16.5%). BALCHEM CORP produced more free cash flow last quarter ($33.8M vs $3.4M).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
BCPC vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $270.8M |
| Net Profit | $40.3M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | 20.5% | -13.2% |
| Net Margin | 14.9% | 0.7% |
| Revenue YoY | 8.1% | -16.5% |
| Net Profit YoY | 8.7% | -83.6% |
| EPS (diluted) | $1.25 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $270.8M | ||
| Q3 25 | $267.6M | — | ||
| Q2 25 | $255.5M | $277.7M | ||
| Q1 25 | $250.5M | $324.5M | ||
| Q4 24 | $240.0M | — | ||
| Q3 24 | $239.9M | — | ||
| Q2 24 | $234.1M | $305.7M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $2.0M | ||
| Q3 25 | $40.3M | — | ||
| Q2 25 | $38.3M | $455.0M | ||
| Q1 25 | $37.1M | $11.9M | ||
| Q4 24 | $33.6M | — | ||
| Q3 24 | $33.8M | — | ||
| Q2 24 | $32.1M | $25.8M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | 37.7% | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | 0.1% | ||
| Q1 25 | 35.2% | 48.0% | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | 41.1% |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | -13.2% | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.1% | -1.3% | ||
| Q1 25 | 20.4% | -5.0% | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 19.6% | -9.0% |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 0.7% | ||
| Q3 25 | 15.1% | — | ||
| Q2 25 | 15.0% | 163.8% | ||
| Q1 25 | 14.8% | 3.7% | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 14.1% | — | ||
| Q2 24 | 13.7% | 8.4% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $0.00 | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | $0.52 | ||
| Q1 25 | $1.13 | $0.01 | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $1.3B | $1.2B |
| Total Assets | $1.7B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $1.4B | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $65.4M | $1.4B | ||
| Q1 25 | $49.9M | $836.1M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $63.7M | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.2B | $759.9M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | $740.1M |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | $1.8B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $8.2M |
| Free Cash FlowOCF − Capex | $33.8M | $3.4M |
| FCF MarginFCF / Revenue | 12.5% | 1.2% |
| Capex IntensityCapex / Revenue | 2.3% | 1.8% |
| Cash ConversionOCF / Net Profit | 0.99× | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $8.2M | ||
| Q3 25 | $65.6M | — | ||
| Q2 25 | $47.3M | $-72.9M | ||
| Q1 25 | $36.5M | $40.3M | ||
| Q4 24 | $52.3M | — | ||
| Q3 24 | $51.3M | — | ||
| Q2 24 | $45.0M | $-39.8M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 4.21× | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | -0.16× | ||
| Q1 25 | 0.98× | 3.38× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
